REF-1622 · Bickel, Cross & Bamman, 2011 · Medicine & Science in Sports & Exercise · Paper · PubMed

Older adults needed more to keep their new muscle: in a trial of 70 adults aged 20-35 or 60-75, 16 weeks of resistance training 3 days a week was followed by 32 weeks of randomly assigned detraining or training at one-third or one-ninth of that dose, and both reduced doses held the muscle hypertrophy in the young (one-third even added fibre size) but not in the older group; the strength gained was largely kept even by those who stopped, with only a slight drop at the last test

Main caveat: Abstract only: no numbers of any kind, so neither the size of the age difference nor how much strength was lost can be read.
moderate evidenceMeasured on non-athletes and recreational peopleRead from the abstract only

Bickel, Cross and Bamman asked how little resistance training is enough to keep what a training block built, and whether older adults need more than young ones. Seventy adults, in a group aged 20-35 and a group aged 60-75, trained 3 days a week for 16 weeks.

For the next 32 weeks they were randomly assigned to stop (detraining) or to keep training at one-third or one-ninth of the phase-1 dose. The first phase produced the expected gains in strength, muscle fibre size and muscle mass, and the usual shift of type IIx fibres toward type IIa.

In the young, both reduced doses held the gained muscle size, and the one-third dose added further fibre growth; in the older group, neither held it. Stopping reversed the fibre-type shift at both ages, and of the two maintenance doses, one-third kept the shift better.

Strength gained in phase 1 was mostly kept even by those who stopped, slipping slightly only by the final test. The authors conclude that older adults need a larger weekly loading dose than the young to keep fibre hypertrophy, while their gains in specific strength held up well and stayed at or above the level of untrained young adults.

Participants

n = 70 adults in two age groups, 20-35 y and 60-75 y; men and women by the PubMed indexing (the abstract does not give the sex split). Not in the abstract: the number in each age group and in each phase-2 arm, how many finished, health status, body size and prior training.

Protocol

Phase 1 (16 weeks): resistance training 3 days a week, described in the conclusion as progressive. Exercises, sets, repetitions and loads: not in the abstract.
Phase 2 (32 weeks): random assignment to detraining or to one of two maintenance prescriptions, the dose cut to one-third or to one-ninth of phase 1. Whether the cut came from fewer days, fewer sets or both: not in the abstract.
Measures: muscle mass, myofiber size and fibre-type distribution, and strength. Methods (imaging, biopsy site, strength tests) and the number of time points: not in the abstract.
Hypothesis: the minimum dose to keep the adaptations would be larger in the older group.

Key Results

Over the 32 weeks of phase 2Younger (20-35 y)Older (60-75 y)
Muscle hypertrophy, one-third dosekept, with further fibre growthnot kept
Muscle hypertrophy, one-ninth dosekeptnot kept
Muscle hypertrophy, detrainingnot stated in the abstractnot stated in the abstract
IIx-to-IIa fibre-type shift, detrainingreversedreversed
Fibre-type shift, maintenancedose response: held better at one-third than one-ninth (the sentence covers both ages)as for the younger group
Strength: the phase-1 gain was largely kept throughout detraining, with a slight fall only at the final time point; the abstract does not split this by age or report the maintenance arms' strength separately.
Specific strength in the older group: well preserved, at or above the level of the untrained young (the abstract does not define specific strength; the term usually means strength per unit of muscle size, our gloss).
No numbers: the abstract gives no percentages, effect sizes, p-values or group sizes.

Practical Application

Cutting the dose hard kept muscle in young adults, not in older ones. After 16 weeks at 3 days a week, one-third and one-ninth of that dose both held the gained muscle size for 32 weeks in 20-35-year-olds, and one-third added more fibre size; in 60-75-year-olds neither held it. An older lifter who wants to keep muscle needs more weekly loading than a young one.
Strength was the easiest thing to keep. Even stopping for 32 weeks left most of the strength gained, with a slight loss by the final test. The abstract does not quantify "largely", so this is a direction, not a number.
More maintenance kept more of the fibre-type change. One-third of the dose held the IIx-to-IIa shift better than one-ninth, and stopping reversed it at both ages. This is a tissue measure; what it means for performance was not tested here.
The abstract does not say what one-third and one-ninth are in days and sets. Not from this paper: the narrative review in REF-587 summarises the maintenance literature as one session and one set per exercise a week for younger people and up to two sessions and 2-3 sets for older people, with relative load kept; this abstract supports the age difference but does not give those doses itself; the review's 32-week window matches this trial's phase 2, so its figures may come from this trial rather than add to it (our reading), and ACSM's 2026 position stand could not establish minimal-dose programmes (REF-1476).
Inference, not tested here: "strength is kept" does not mean the gym can stop in season. These were adults after a single 16-week block, with no endurance training on top. In professional soccer players, one in-season session every second week lost leg strength and sprint speed within 12 weeks while one a week held them (REF-1628), and the base's strength guides keep a lower but never-zero dose in season (SYNTH-43, SYNTH-44).

Limitations

Abstract only: no numbers of any kind, so neither the size of the age difference nor how much strength was lost can be read.
Group sizes, dropouts and the sex split are not in the abstract; about 12 per age-by-arm group is our arithmetic and assumes everyone reached phase 2.
The doses behind one-third and one-ninth are not in the abstract.
Adults new to the programme after one 16-week block; trained athletes, and athletes doing endurance work alongside, may hold or lose adaptations differently.
The fibre-type result is a tissue marker; the hypertrophy and strength results carry the practical weight.
Strength retention is reported for the detraining group without an age split.
How this entry was checked and changed
Why this level

parallel randomised phase 2 within two age groups: 70 adults over six age-by-arm groups is at most about 12 per group (our arithmetic, 70/6 = 11.7, and only if all 70 entered phase 2; the abstract gives no phase-2 numbers or dropouts), just inside the rubric's 10–19 per arm; losing more than 10 people would put it under 10 per arm (B), and a trial read from the abstract alone goes no higher; the abstract reports directions only, with no numbers

Content correction 2026-11-06
2026-11-06: added from the abstract and the PubMed record; level B+ (parallel randomised phase 2, about 12 per age-by-arm group by our arithmetic; abstract only).